SEC Form 3 · accession 0001193125-26-402904
Hemab Therapeutics Holdings, Inc. · COAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keli Walbert
Director
Period of report
Sep 24, 2026
Accepted (ET)
Sep 25, 2026 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0002114044
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.
Remarks
24.1 Power of Attorney